Artigo Acesso aberto Revisado por pares

Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy

2009; Lippincott Williams & Wilkins; Volume: 24; Issue: 1 Linguagem: Inglês

10.1097/qad.0b013e32832e5303

ISSN

1473-5571

Autores

Roger Paredes, Irene H. Cheng, Daniel R. Kuritzkes, Ruth Tuomala,

Tópico(s)

HIV Research and Treatment

Resumo

Pregnancy-limited antiretroviral therapy (PLAT) drastically reduces HIV-1 transmission to the newborn, but may select for antiretroviral drug resistance mutations in mothers.

Referência(s)